ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 171 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2024. The put-call ratio across all filers is 1.18 and the average weighting 0.1%.
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Vida Ventures Advisors, LLC | 1,798,163 | $4,189,720 | 4.58% |
| SUPERSTRING CAPITAL MANAGEMENT LP | 689,912 | $1,607,495 | 2.03% |
| Lynx1 Capital Management LP | 2,228,295 | $5,191,927 | 1.87% |
| Wildcat Capital Management, LLC | 2,920,787 | $6,805,434 | 1.66% |
| TPG GP A, LLC | 18,716,306 | $43,608,993 | 1.00% |
| Boxer Capital, LLC | 3,850,000 | $8,970,500 | 0.47% |
| Vestal Point Capital, LP | 2,200,000 | $5,126,000 | 0.38% |
| DAFNA Capital Management LLC | 605,100 | $1,409,883 | 0.34% |
| Frazier Life Sciences Management, L.P. | 2,867,750 | $6,681,858 | 0.31% |
| Coastal Bridge Advisors, LLC | 406,847 | $947,954 | 0.24% |
| Perceptive Advisors | 2,725,000 | $6,349,250 | 0.15% |
| GSA CAPITAL PARTNERS LLP | 835,342 | $1,946 | 0.14% |
| Woodline Partners LP | 4,358,989 | $10,156,444 | 0.10% |
| Pennant Investors, LP | 128,400 | $299,172 | 0.08% |
| BOURGEON CAPITAL MANAGEMENT LLC | 132,455 | $308,621 | 0.06% |
| Navalign, LLC | 75,365 | $175,600 | 0.06% |
| Virtus ETF Advisers LLC | 35,640 | $83,041 | 0.04% |
| CAXTON ASSOCIATES LP | 466,110 | $1,086,036 | 0.04% |
| CORNERCAP INVESTMENT COUNSEL INC | 63,470 | $147,885 | 0.02% |
| SUSQUEHANNA FUNDAMENTAL INVESTMENTS, LLC | 418,699 | $975,569 | 0.02% |
External links
This page lists ALLOGENE THERAPEUTICS INC's shareholders in Q2 2024. To view ALLOGENE THERAPEUTICS INC's shareholder history, click here.